Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.0300
+0.0030 (11.11%)
Jan 22, 2025, 9:36 AM EST

Ayala Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022
Period Ending
Jan '25 Dec '23 Dec '22
Market Capitalization
18-
Enterprise Value
57-
Last Close Price
0.030.67-
PS Ratio
12.51610.40-
PB Ratio
-0.32-0.32-
EV/Sales Ratio
559.86559.86-
Debt / Equity Ratio
-0.34-0.34-1.59
Asset Turnover
0.000.00-
Quick Ratio
0.200.200.43
Current Ratio
0.300.300.51
Return on Assets (ROA)
-181.05%-181.05%-
Earnings Yield
-29580.09%-605.81%-
FCF Yield
-371.57%-371.57%-
Buyback Yield / Dilution
-107.90%-
Total Shareholder Return
-107.90%-
Source: S&P Capital IQ. Standard template. Financial Sources.